Polynovo Director’s Shareholding Adjusted by Personal Gift

Tip Ranks
2025.01.14 02:22
portai
I'm PortAI, I can summarize articles.

Polynovo Limited (AU:PNV) announced a change in director David Williams' shareholding due to a personal gift. His spouse's entity, Lawn Views Pty Ltd, gifted 750 shares, reducing their total holdings to 21,420,635 shares. This off-market transaction has no direct impact on Polynovo's operations or market position. Polynovo focuses on developing innovative medical devices, particularly biodegradable polymers for treating burns and wounds, with a current market cap of $882.9M and a year-to-date price performance of 12.50%.

Stay Ahead of the Market:

  • Discover outperforming stocks and invest smarter with Top Smart Score Stocks
  • Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener

An update from Polynovo Limited ( (AU:PNV) ) is now available.

Polynovo Limited has announced a change in the director’s interest in securities, specifically noting that director David Williams’ spouse’s affiliated entity, Lawn Views Pty Ltd, gifted 750 ordinary shares as a wedding present, reducing their total holdings to 21,420,635 shares. This off-market transaction reflects a personal gifting decision, with no direct implications on Polynovo’s strategic operations or market positioning.

More about Polynovo Limited

Polynovo Limited operates within the medical technology industry, focusing on developing and commercializing innovative medical devices. Their primary products include biodegradable polymers used in the treatment of burns, surgical wounds, and other skin-related injuries, with a market focus on improving patient outcomes and advancing medical treatments.

YTD Price Performance: 12.50%

Average Trading Volume: 3,631

Technical Sentiment Consensus Rating: Hold

Current Market Cap: $882.9M

Find detailed analytics on PNV stock on TipRanks’ Stock Analysis page.

Trending Articles:

  • ‘Think Long Term,’ Says Investor About Palantir Stock
  • ‘The Road Remains Bumpy,’ Says Goldman Sachs About AMD Stock
  • ‘Buckle Up for Another Surge,’ Says Investor About MicroStrategy Stock